GlassScriptPhysician profile
Michael J Gerwe
NPI 1124023429
$2,468.64
in general payments reported to CMS, 2019-2025
24 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $164 · 2021: $62.18 · 2022: $839 · 2023: $18.08 · 2024: $963 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $768 · Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $767.75 |
| Food and Beverage | $358.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $841.84 | 2024 | |
| Applied Medical Resources Corporation | $437.03 | 2022 | |
| Gynesonics, INC. | $307.49 | 2022 | |
| Abbvie INC. | $242.46 | 2019-2022 | |
| Avanos Medical | $132.87 | 2019 | |
| Ethicon US, LLC | $87.73 | 2021-2025 | Vistaseal |
| Daiichi Sankyo INC. | $47.06 | 2019-2022 | |
| Astellas Pharma US INC | $40.67 | 2023-2024 | Veozah |
| Meditrina | $38.06 | 2021 | |
| Exeltis, USA INC. | $29.14 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $27.96 | 2019 | |
| Sage Therapeutics, LLC | $25.96 | 2024 | |
| Millicent US INC | $24.86 | 2025 | Femlyv |
| Pfizer INC. | $24.28 | 2022 | |
| Mayne Pharma Commercial LLC | $22.19 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $19.22 | 2024 | |
| Baxter Healthcare | $18.25 | 2024 | Perclot |
| Grifols USA, LLC | $18.20 | 2025 | Thrombate III |
| Shield Therapeutics INC | $17.83 | 2024 | |
| Novo Nordisk INC | $17.25 | 2024 | Wegovy |
| Vertical Pharmaceuticals, LLC | $12.92 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.76 | 2019 | |
| Minerva Surgical, INC | $11.76 | 2022 | |
| Allergan, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gerwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.